Capital for the long production cycle.
You buy active ingredients and fund validation, clean rooms, and payroll long before product clears and gets paid. For pharmaceutical manufacturers nationwide.
We know how pharmaceutical operations really run.
Financing built around your industry's real cash-flow rhythm — not a one-size-fits-all bank box.
How each option works
The programs our lending partners actually offer businesses like yours. Not sure which one? Check your options and we'll match the structure to the deal.
Equipment Financing
Get the equipment. Keep your cash.
See terms & details →Asset-Based Lending
Borrow against what your business owns.
See terms & details →Purchase Order Financing
Fund the order before you're paid.
See terms & details →Invoice Factoring
Get paid now, not in 60 days.
See terms & details →Want the full picture first? Get a free Capital Position Report — where your business stands and what it likely qualifies for.
The pressure points we solve
The cash-flow squeezes we hear about most — and the fair fix for each.
The squeezeIngredient and testing costs come first.
The fair fixGet working capital fast so you can source inputs and run production on time.
The squeezeClean-room and equipment upgrades are heavy.
The fair fixFund facility work with fixed, predictable payments instead of a daily debit.
The squeezeLong cycles stretch your cash thin.
The fair fixInterest-only and flexible options bridge the gap with far less paperwork.
What manufacturers use it for
Put the capital where it moves the needle most.
Active ingredients
Production equipment
Clean-room expansion
Payroll
Fulfilling large orders
R&D and validation
Related industries
Businesses with a similar cash-flow rhythm, and the financing we see them use.
Tools and guides for drug & pharmaceutical manufacturing
Run the numbers
From our insights
What it takes to qualify
Most deals here are secured by equipment, trucks, receivables, or property — but if you need cash-flow financing, that path qualifies differently.
Real Estate & Assets
- Credit generally 620+ (equipment) to 640+ (rental property)
- Equity or down payment — typically up to ~75% loan-to-value
- The property's income covers the payment (DSCR programs)
- No tax returns required on most DSCR programs
- Entity docs, insurance, and a purchase contract or payoff statement
Business Capital
- Operating at least a few months under current ownership
- Roughly $17,000+ per month in business revenue
- Personal credit around 575+ on most programs
- Not over-extended on existing cash advances
- Bank statements usually enough to start — no tax returns to check options
Guidelines are typical ranges across our lender network, not a commitment to lend — every deal is reviewed individually.
Ready to fund your pharmaceutical operation?
Two minutes, no obligation, no credit impact. Or call (337) 270-2036.
